AN2 Therapeutics
intellectual property up to years of exclusivity united states japan composition of matter patent expires june without hatch waxman extensions pediatric exclusivity up to years of extensions protection up to june regulatory exclusivity up to years post marketing orphan drug years gain act years patents issued in provides years of exclusivity from launch with as similar mechanisms available in japan an therapeutics | AN2 Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2022
Slide
23 of 27
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
Investor Presentation
August 2022
intellectual property up to years of exclusivity united states japan patents issued in composition of matter patent expires june without hatch waxman extensions pediatric exclusivity up to years of extensions protection up to june orphan drug years gain act years available an therapeutics | AN2 Therapeutics
Related slides by other companies
Kering
Investor Day
June 2022
distribution geographies | Kering
MindMed
Investor Day
June 2023
intellectual property in basics | MindMed
Associated British Foods
Results
November 2023
performance | Associated British Foods
Wix
Results
February 2023
broad geographic reach | Wix
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io